Biotech

AAV virus capsid
Biotech

Vertex discontinues AAV research for gene therapies

Despite the shift away from AAVs, a company spokesperson affirmed that Vertex’s “commitment to cell and genetic therapies remains strong.”
Darren Incorvaia May 2, 2025 6:22pm
Concept of loss of money downward arrow made of dollar banknotes on white background

'Too big and unfocused': Trump slashes NIH budget by $18B

May 2, 2025 2:42pm
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
finch canary cage free bird release

FDA lifts hold on Amgen's phase 1 obesity study

May 2, 2025 10:10am
Guidehouses Karla Anderson shares top tips for successful biotech commercialization

Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization

Oct 28, 2024 8:00am
London Cancer Hub

UK unveils £1B plan to become leading cancer research hub

May 2, 2025 9:25am